Capital Flow Monitor · Sponsors · CIK 2136590
Third Rock Ventures VII, L.P.
201 Brookline Ave, Suite 1401, Boston, MA, 02215 · 617-585-2000
Pooled Investment Fund / Venture Capital Fund · Limited Partnership· inc. DELAWARE true 2026
Fit score
—
Offering
$750.0M
Sold
$0
% sold
0.0%
Investors
0
Min investment
$300K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-03 | D ·current | 506(b) | $750.0M | $0 | 0.0% | 0 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- N/A Third Rock Ventures GP VII, L.P. — Executive Officer, Boston, MA
- N/A TRV GP VII, LLC — Executive Officer, Boston, MA
- Kevin Gillis — Executive Officer, Boston, MA
-
Reid Huber — Executive Officer, Boston, MA
1 other raise
- Terremoto Biosciences, Inc. $40.7M of $108.6M · 37.5%
-
Jigar Raythatha — Executive Officer, Boston, MA
1 other raise
- Triana Biomedicines, Inc. $120.1M of $120.1M · 100.0%
- Jeffrey Tong — Executive Officer, San Francisco, CA
- Andrea van Elsas — Executive Officer, San Francisco, CA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.